These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 20726702)

  • 1. Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model.
    Kennedy AD; Bubeck Wardenburg J; Gardner DJ; Long D; Whitney AR; Braughton KR; Schneewind O; DeLeo FR
    J Infect Dis; 2010 Oct; 202(7):1050-8. PubMed ID: 20726702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of antibodies in protection elicited by active vaccination with genetically inactivated alpha hemolysin in a mouse model of staphylococcus aureus skin and soft tissue infections.
    Mocca CP; Brady RA; Burns DL
    Clin Vaccine Immunol; 2014 May; 21(5):622-7. PubMed ID: 24574539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections.
    Adhikari RP; Thompson CD; Aman MJ; Lee JC
    Vaccine; 2016 Dec; 34(50):6402-6407. PubMed ID: 27847174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-Mediated Protection against Staphylococcus aureus Dermonecrosis: Synergy of Toxin Neutralization and Neutrophil Recruitment.
    Yang C; Ruiz-Rosado JD; Robledo-Avila FH; Li Z; Jennings RN; Partida-Sanchez S; Montgomery CP
    J Invest Dermatol; 2021 Apr; 141(4):810-820.e8. PubMed ID: 32946878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Protection in a Rabbit Model of Community-Associated Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia upon Neutralization of Leukocidins in Addition to Alpha-Hemolysin.
    Diep BA; Le VT; Visram ZC; Rouha H; Stulik L; Dip EC; Nagy G; Nagy E
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6333-40. PubMed ID: 27527081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical Role of Alpha-Toxin and Protective Effects of Its Neutralization by a Human Antibody in Acute Bacterial Skin and Skin Structure Infections.
    Le VT; Tkaczyk C; Chau S; Rao RL; Dip EC; Pereira-Franchi EP; Cheng L; Lee S; Koelkebeck H; Hilliard JJ; Yu XQ; Datta V; Nguyen V; Weiss W; Prokai L; O'Day T; Stover CK; Sellman BR; Diep BA
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5640-8. PubMed ID: 27401576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Hemolysin-mediated endothelial injury contributes to the development of
    Yang C; Robledo-Avila FH; Partida-Sanchez S; Montgomery CP
    Infect Immun; 2024 Aug; 92(8):e0013324. PubMed ID: 38953668
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccination with VLPs Presenting a Linear Neutralizing Domain of
    Joyner JA; Daly SM; Peabody J; Triplett KD; Pokhrel S; Elmore BO; Adebanjo D; Peabody DS; Chackerian B; Hall PR
    Toxins (Basel); 2020 Jul; 12(7):. PubMed ID: 32664481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate Sex Bias of
    Castleman MJ; Pokhrel S; Triplett KD; Kusewitt DF; Elmore BO; Joyner JA; Femling JK; Sharma G; Hathaway HJ; Prossnitz ER; Hall PR
    J Immunol; 2018 Jan; 200(2):657-668. PubMed ID: 29222165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IBT-V02: A Multicomponent Toxoid Vaccine Protects Against Primary and Secondary Skin Infections Caused by
    Karauzum H; Venkatasubramaniam A; Adhikari RP; Kort T; Holtsberg FW; Mukherjee I; Mednikov M; Ortines R; Nguyen NTQ; Doan TMN; Diep BA; Lee JC; Aman MJ
    Front Immunol; 2021; 12():624310. PubMed ID: 33777005
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of anti-alpha toxin monoclonal antibodies that reduce the severity of Staphylococcus aureus dermonecrosis and exhibit a correlation between affinity and potency.
    Tkaczyk C; Hua L; Varkey R; Shi Y; Dettinger L; Woods R; Barnes A; MacGill RS; Wilson S; Chowdhury P; Stover CK; Sellman BR
    Clin Vaccine Immunol; 2012 Mar; 19(3):377-85. PubMed ID: 22237895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting surface protein SasX by active and passive vaccination to reduce Staphylococcus aureus colonization and infection.
    Liu Q; Du X; Hong X; Li T; Zheng B; He L; Wang Y; Otto M; Li M
    Infect Immun; 2015 May; 83(5):2168-74. PubMed ID: 25776748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcus aureus Fatty Acid Kinase FakA Modulates Pathogenesis during Skin Infection via Proteases.
    Ridder MJ; Daly SM; Triplett KD; Seawell NA; Hall PR; Bose JL
    Infect Immun; 2020 Jul; 88(8):. PubMed ID: 32513856
    [No Abstract]   [Full Text] [Related]  

  • 14. Liposomal Therapy Attenuates Dermonecrosis Induced by Community-Associated Methicillin-Resistant Staphylococcus aureus by Targeting α-Type Phenol-Soluble Modulins and α-Hemolysin.
    Wolfmeier H; Mansour SC; Liu LT; Pletzer D; Draeger A; Babiychuk EB; Hancock REW
    EBioMedicine; 2018 Jul; 33():211-217. PubMed ID: 29936135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300.
    Brown EL; Dumitrescu O; Thomas D; Badiou C; Koers EM; Choudhury P; Vazquez V; Etienne J; Lina G; Vandenesch F; Bowden MG
    Clin Microbiol Infect; 2009 Feb; 15(2):156-64. PubMed ID: 19154186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commensal
    Yang JJ; Chang TW; Jiang Y; Kao HJ; Chiou BH; Kao MS; Huang CM
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29693635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel structurally designed vaccine for S. aureus α-hemolysin: protection against bacteremia and pneumonia.
    Adhikari RP; Karauzum H; Sarwar J; Abaandou L; Mahmoudieh M; Boroun AR; Vu H; Nguyen T; Devi VS; Shulenin S; Warfield KL; Aman MJ
    PLoS One; 2012; 7(6):e38567. PubMed ID: 22701668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine protection against Staphylococcus aureus pneumonia.
    Bubeck Wardenburg J; Schneewind O
    J Exp Med; 2008 Feb; 205(2):287-94. PubMed ID: 18268041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action and in vivo efficacy of a human-derived antibody against Staphylococcus aureus α-hemolysin.
    Foletti D; Strop P; Shaughnessy L; Hasa-Moreno A; Casas MG; Russell M; Bee C; Wu S; Pham A; Zeng Z; Pons J; Rajpal A; Shelton D
    J Mol Biol; 2013 May; 425(10):1641-54. PubMed ID: 23416200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The arginine catabolic mobile element is not associated with enhanced virulence in experimental invasive disease caused by the community-associated methicillin-resistant Staphylococcus aureus USA300 genetic background.
    Montgomery CP; Boyle-Vavra S; Daum RS
    Infect Immun; 2009 Jul; 77(7):2650-6. PubMed ID: 19380473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.